Single Subject Neratinib in Bladder Cancer (NRR)

NCT01956253 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Neratinib

Sponsor

UNC Lineberger Comprehensive Cancer Center